Previsão

Não temos dados de analistas para esta empresa.

Notícias Ir para o feed de notícias

West Pharmaceutical reports cyberattack and temporary operational disruptions

West Pharmaceutical discovered a cyberattack on May 4 in which data were exfiltrated and systems were encrypted. The company shut down systems worldwide, notified law enforcement and hired IT forensics experts; key systems have already been partially restored and shipping, goods receipt and manufacturing have resumed at some sites. Recovery is still ongoing at other locations, there is no timetable for full restoration, and the financial impact cannot currently be quantified. » Mais em de.investing.com
West Pharmaceutical raises forecast and outlines growth strategy at Wells‑Fargo conference

West Pharmaceutical raised its organic revenue growth forecast for 2025 from 2–3% to 3–4% and increased the EPS forecast by $0.50 after strong demand for GLP‑1 components and drug delivery systems. CFO Bob McMahon emphasized operational strength, the focus on SmartDose to improve profitability (including automation or divestiture options), and investments in contract manufacturing in the US and Ireland. The company expects capacity expansions and contract manufacturing to have a positive impact on free cash flow from 2026 and sees mid‑term HVP growth in the mid‑ to high‑single digits to low‑double digits. » Mais em de.investing.com

Dividendos históricos Dividendos

Todos os indicadores de dividendos Todos os indicadores

Em 2026, West Holdings já distribuiu € 0,19 em dividendos. A última distribuição ocorreu em maio.

Dados financeiros da empresa

No último trimestre, West Holdings registou receitas de € 76,27 mi e um ganho líquido de € 10,55 mi

(EUR)	maio de 2026	YoY
Receitas	76,27 mi	74,80%
Ganho bruto	27,25 mi	80,40%
Ganho líquido	10,55 mi	652,93%
EBITDA	22,02 mi	161,62%

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 530,87 mi
Número de ações	39,66 mi
Máximo/mínimo de 52 semanas	€ 18,34 - € 7,26
Rentabilidade de dividendos	1,51%
Dividendos TTM	€ 0,19
Beta	0,74
PER (PE Ratio)	13,72
PEG (PEG Ratio)	0,34
P/VC (PB Ratio)	2,70
P/V (PS Ratio)	1,73

Perfil da empresa

West Holdings Corporation ist im Bereich der erneuerbaren Energien tätig. Das Unternehmen ist in der Installation von Solarstromanlagen für Privathaushalte und Industrieanlagen, Boden- und Dachanlagen für Fabriken, dem Bau und Verkauf von öffentlichen und industriellen Photovoltaikanlagen, der Erzeugung und dem Verkauf von Solarstrom, der Verwaltung und Wartung von Photovoltaikanlagen und zugehöriger Ausrüstung sowie der Erbringung von Energiespardienstleistungen tätig. Das Unternehmen wurde 1981 gegründet und hat seinen Hauptsitz in Tokio, Japan.